These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30182910)

  • 41. Hepatitis C: only a step away from elimination?
    Lancet; 2015 Mar; 385(9973):1045. PubMed ID: 25797543
    [No Abstract]   [Full Text] [Related]  

  • 42. Remaining challenges in HCV elimination.
    Capraru C; Feld JJ
    J Hepatol; 2021 Apr; 74(4):964-965. PubMed ID: 33589319
    [No Abstract]   [Full Text] [Related]  

  • 43. [Progress, challenges and countermeasures of global hepatitis C elimination].
    Chen ZD
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):812-816. PubMed ID: 33105922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Global hepatitis C elimination: an investment framework.
    Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excellence in viral hepatitis elimination - Lessons from Georgia.
    Averhoff F; Lazarus JV; Sergeenko D; Colombo M; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Hellard M; Gnes S; Gabunia T; Nasrullah M
    J Hepatol; 2019 Oct; 71(4):645-647. PubMed ID: 31356831
    [No Abstract]   [Full Text] [Related]  

  • 46. A path to eradication of hepatitis C in low- and middle-income countries.
    Graham CS; Swan T
    Antiviral Res; 2015 Jul; 119():89-96. PubMed ID: 25615583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Editorial overview: Antiviral strategies: Virological and immunological basis for HBV cure.
    Urban S; Bertoletti A
    Curr Opin Virol; 2018 Jun; 30():iv-vi. PubMed ID: 29866361
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of hepatitis C with new direct antiviral drugs: towards a disease cure].
    Halfon P; Cacoub P
    Rev Med Interne; 2014 Apr; 35(4):219-21. PubMed ID: 24559772
    [No Abstract]   [Full Text] [Related]  

  • 49. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example.
    Altraif I
    Saudi Med J; 2018 Aug; 39(8):842-845. PubMed ID: 30106425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C could be virtually eliminated by 2030, experts believe.
    Watts G
    BMJ; 2014 Apr; 348():g2700. PubMed ID: 24721972
    [No Abstract]   [Full Text] [Related]  

  • 51. HCV Eradication: A Duty of the State, an Option for the Individual.
    Craxì L
    Adv Exp Med Biol; 2020; 1282():85-91. PubMed ID: 31808124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus vaccines in the era of new direct-acting antivirals.
    Shi C; Ploss A
    Expert Rev Gastroenterol Hepatol; 2013 Feb; 7(2):171-85. PubMed ID: 23363265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Achieving Hepatitis C Elimination By Using Person-Centered, Nurse-Led Models of Care: A Discussion of Four International Case Studies.
    Richmond JA; Gallagher L; McDonald L; O'Sullivan M; Fitzsimmons C; Pedrana A
    Gastroenterol Nurs; 2020; 43(4):303-309. PubMed ID: 32665524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The management of hepatitis B and hepatitis C in children.
    Batsis ID; Wasuwanich P; Karnsakul WW
    Minerva Pediatr; 2019 Feb; 71(1):59-75. PubMed ID: 30334626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One step closer to elimination of hepatitis C in Egypt.
    Esmat G; El-Sayed MH; Hassany M; Doss W; Waked I;
    Lancet Gastroenterol Hepatol; 2018 Oct; 3(10):665. PubMed ID: 30215356
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatitis C virus elimination: laying the foundation for achieving 2030 targets.
    Dore GJ; Bajis S
    Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):91-92. PubMed ID: 33257831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030.
    Sonderup MW; Afihene M; Ally R; Apica B; Awuku Y; Cunha L; Dusheiko G; Gogela N; Lohouès-Kouacou MJ; Lam P; Lesi O; Mbaye PS; Musabeyezu E; Musau B; Ojo O; Rwegasha J; Scholz B; Shewaye AB; Tzeuton C; Kassianides C; Spearman CW;
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):910-919. PubMed ID: 29132760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging pipeline drugs for hepatitis B infection.
    Cox N; Tillmann H
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):713-29. PubMed ID: 22195605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
    Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
    Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.